The global pharmacovigilance market is growing significantly due to increasing concern for drug safety, increasing incidences of adverse drug reactions and toxicity, and high patient compliance for drug usage. In addition, government and non-government organizations are actively involved in determining drug safety and efficacy, which in turn is supporting growth of global pharmacovigilance market. Massive unexplored pharmacovigilance market in emerging economies and increasing pharmaceutical companies’ compliance for outsourcing services are creating ample opportunities for the global pharmacovigilance market.

View Full Report with TOC @      

Pharmacovigilance is the process of monitoring and preventing adverse drug reactions. According to the WHO, pharmacovigilance can be defined as the science and activities concerned with the detection, assessment, understanding and prevention of adverse reactions to medicine. Pharmacovigilance determines drug safety and efficacy and improves patient care and public health by preventing adverse drug reactions. Adverse drug reaction is harmful, unintended, and uncomfortable effects of a drug. According to the studies conducted by WHO in developed countries, approximately 5% of hospitalized patients are admitted in the hospitals due to adverse drug reaction, and 6-10% of these patients would suffer from serious adverse drug reactions. Pharmaceutical and biotechnology companies are actively involved in the development of new drugs; this creates an increased demand for pharmacovigillance.

The global pharmacovigilance market can be categorized as pharmacovigilance methods, service providers, and different phases of drug development. Based on pharmacovigilance methods, the pharmacovigilance market is categorized as spontaneous reporting, targeted spontaneous reporting, electronic health record mining, cohort event monitoring, and intensified adverse drug reaction reporting. Based on service providers, the global pharmacovigilance market can be categorized as in-house pharmacovigilance and contract outsourcing pharmacovigilance. The contract outsourcing pharmacovigilance leads the global pharmacovigilance market and is expected to grow at a higher rate in the coming years.

Browse All Reports of This Category @    

On the basis of different phases of clinical trial, the global pharmacovigilance market is categorized as preclinical research, phase I clinical trial, phase II clinical trial, phase III clinical trial, and phase IV clinical trial. The phase IV clinical trial segment leads the global pharmacovigilance market.

The major drivers in the global pharmacovigilance market are increasing incidences of adverse drug reactions and toxicity, increasing patient compliance for drug usage, and increasing concern for drug safety and efficacy. In addition, increasing involvement of government and non-government organization to determine drug safety and efficacy is propelling the growth of the global pharmacovigilance market. On the other hand, high risk of data breach through outsourcing of pharmacovigilance and shortage of skilled professionals are some of the factors restraining the growth of the global pharmacovigilance market to some extent.

For More Information visit: Acute Market Reports

About Acute Market Reports

Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. Acute Market Reports provide online reports from over 100 best publishers and upgrade Acute Market Reports collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends. Acute Market Reports database consists of 200,000+ market research reports with detailed & minute market research.


Chris Paul

Office No 01, 1st Floor,

Aditi Mall, Baner, Pune,

MH, 411045 India

Phone (India): +91 7755981103

Toll Free (US/Canada): +1-855-455-8662